Skip to main navigation menu Skip to main content Skip to site footer
×
Español (España) | English
Editorial
Home
Indexing
Original

Relationship between Serum Vascular Endothelial Growth Factor-A Levels and Response to Chemotherapy in Cervical Cancer

By
Milha Nidiya Marni ,
Milha Nidiya Marni

Airlangga University, Master Student in Reproductive Health Sciences, Faculty of Medicine, Surabaya, Indonesia, Country

Search this author on:

PubMed | Google Scholar
Pungky Mulawardhana ,
Pungky Mulawardhana

Airlangga University, Department of Obstetrics and Gynecology, Faculty of Medicine, Surabaya, Indonesia

Search this author on:

PubMed | Google Scholar
Puspa Wardhani ,
Puspa Wardhani

Airlangga University, Department of Clinical Pathology, Faculty of Medicine, Surabaya, Indonesia

Search this author on:

PubMed | Google Scholar

Abstract

Introduction: Cervical cancer ranks second in gynecological cancer worldwide. 62-82% of cervical cancer patients present at an advanced stage and respond poorly to treatment. Assessment of chemotherapy response requires examination of the biomarker Vascular endothelial growth factor-A (VEGF-A), which is the main regulator of the abnormal angiogenesis process.
Objectives: This study aims to analyze the relationship between serum VEGF-A levels and the response to neoadjuvant chemotherapy in cervical cancer patients.
Methods: This research is Quasi-Experimental, pretest and posttest without control. Total sample: 30 stages IIIB cervical cancer patients underwent a pretest before cisplatin chemotherapy by measuring cervical lesions using ultrasound and serum VEGF-A levels using ELISA. 3 weeks after the third cycle of chemotherapy, a posttest examination is carried out like the pretest examination.
Results: The results showed a significant reduction in serum VEGF-A levels and cervical lesion diameter after chemotherapy (p=0.032), (p=0.000). In response to neoadjuvant chemotherapy, 21 patients responded negatively, and 9 responded positively. High levels of VEGF-A before chemotherapy gave a negative response (p=0.042) and low levels of VEGF-A after chemotherapy gave a positive response (p=0.049).
Conclusions: This study concludes that there is a relationship between high serum VEGF-A levels before chemotherapy with a negative response and low serum VEGF-A levels after chemotherapy with a positive response in cervical cancer patients.

How to Cite

1.
Nidiya Marni MN, Mulawardhana P, Wardhani P. Relationship between Serum Vascular Endothelial Growth Factor-A Levels and Response to Chemotherapy in Cervical Cancer. Salud, Ciencia y Tecnología [Internet]. 2024 Jun. 14 [cited 2024 Jul. 15];4:967. Available from: https://revista.saludcyt.ar/ojs/index.php/sct/article/view/967

The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.

Article metrics

Google scholar: See link

Metrics

Metrics Loading ...

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.